Litman Gregory Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$865 Buy
+9
New +$874 ﹤0.01% 329
2021
Q2
– Sell
-322
Closed -$38K – 140
2021
Q1
$38K Sell
322
-2,640
-89% -$309K 0.01% 107
2020
Q4
$347K Buy
2,962
+171
+6% +$18.8K 0.06% 52
2020
Q3
$290K Buy
2,791
+11
+0.4% +$1.1K 0.06% 53
2020
Q2
$255K Sell
2,780
-61
-2% -$5.85K 0.06% 54
2020
Q1
$256K Buy
+2,841
New +$302K 0.06% 50
2019
Q4
– Sell
-36
Closed -$4K – 244
2019
Q3
$4K Sell
36
-37
-51% -$3.86K ﹤0.01% 160
2019
Q2
$7K Buy
+73
New +$6.67K ﹤0.01% 161

Other funds holding MDT

Litman Gregory Wealth Management's MDT Position: Q4 2025 in Review

Litman Gregory Wealth Management opened a new position in Medtronic (MDT) in Q4 2025: 9 shares worth $865. The stake represents ﹤0.01% of the portfolio and ranks #329 among its holdings. This is a return to the name: Litman Gregory Wealth Management previously reported a position in MDT as recently as Q1 2021.

Litman Gregory Wealth Management first reported a position in MDT in Q2 2019 and has held it in 8 quarters since. The position peaked at $347K in Q4 2020. 2,319 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Litman Gregory Wealth Management held 9 shares of Medtronic worth $865 as of Q4 2025.
  • Medtronic was a new Litman Gregory Wealth Management position in Q4 2025.
  • Medtronic made up ﹤0.01% of Litman Gregory Wealth Management's portfolio in Q4 2025, its #329 holding.
  • Litman Gregory Wealth Management first reported a position in Medtronic in Q2 2019 and has held it in 8 quarters since.
  • Litman Gregory Wealth Management's Medtronic position peaked at $347K in Q4 2020.
  • 2,319 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Litman Gregory Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.